Tbg Diagnostics Ltd (TDL.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -130 | -271 | -1,350 | -427 | -1,261 |
| Net Acquisitions | N/A | -328 | N/A | N/A | 14,124 |
| Purchase Of Investment | -75 | -2,130 | N/A | N/A | N/A |
| Other Investing Activity | -82 | 1,999 | 1,800 | -71 | -652 |
| Investing Cash Flow | $-287 | $-730 | $450 | $-498 | $12,210 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,852 | 952 | N/A | N/A | N/A |
| Debt Repayment | -2,554 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 413 | 398 | N/A |
| Other Financing Activity | -206 | -185 | 0 | 0 | 0 |
| Financing Cash Flow | $2,092 | $768 | $413 | $398 | $N/A |
| Exchange Rate Effect | 159 | 756 | 681 | -190 | 299 |
| Beginning Cash Position | 5,205 | 6,735 | 7,918 | 10,642 | 6,446 |
| End Cash Position | 3,777 | 5,205 | 6,735 | 7,918 | 14,562 |
| Net Cash Flow | $-1,587 | $-2,286 | $-1,864 | $-2,533 | $7,817 |
| Free Cash Flow | |||||
| Capital Expenditure | -212 | -271 | -1,475 | -498 | -1,913 |
| Free Cash Flow | -212 | -271 | -1,475 | -498 | -1,913 |